Leveraging technology to transform Anatomic Pathology - Insights
As Mayo Clinic’s Anatomic Pathology moves from traditional glass slides to digital images, the advance in technology is achieving clear benefits in collaboration, learning, and patient care.
Modified two-tiered testing for Lyme disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).
Dangerous Goods Training - Insights
Self-paced online training and certification for safe collection, handling, packaging, and shipment of specimens.
MCL Congenital Heart Disease Genetic Testing Patient Information MC1235298
MCL Congenital Heart Disease Genetic Testing Patient Information Complete print Reset Form Congenital Heart Disease Genetic Testing Patient Information Instructions Accurate interpretation reporting genetic results
R. Ross Reichard, M.D., Featured in CAP Today - Insights
R. Ross Reichard, M.D., DLMP Vice Chair of Quality and Associate Chair of Practice, recently contributed to a College of American Pathologists (CAP) article in CAP Today. The article, "How the Laboratory Drives Patient Satisfaction,"...
Multiomics: A new model for identifying biomarkers to predict severe COVID-19 outcomes - Insights
In a groundbreaking study, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better than traditional cytokines. Using a machine-learning-based prediction model, the team...
New high-resolution urine drug testing profile - Insights
Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol,...
An inside look at the state-of-the-art supports enabling invention - Insights
A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that...
The Living Breast Biobank - Insights
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
Cytomegalovirus, or CMV, is a common cause of disease in the transplant population. In some patients who are diagnosed with CMV and are on antiviral treatment for infections, the virus may develop resistance to the drugs. This “Hot Topic”...